Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

Sepideh Mirzaei; Mahmood Khaksary Mahabady; Amirhossein Zabolian; Alireza Abbaspour; Peyman Fallahzadeh; Maedeh Noori; Farid Hashemi; Kiavash Hushmandi; Salman Daneshi; Alan Prem Kumar; Amir Reza Aref; Saeed Samarghandian; Pooyan Makvandi; Haroon Khan; Michael R Hamblin; Milad Ashrafizadeh; Ali Zarrabi

Related publications

Article2021

Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, Alireza Abbaspour, Peyman Fallahzadeh, Maedeh Noori, Farid Hashemi, Kiavash Hushmandi, Salman Daneshi, Alan Prem Kumar, Amir Reza Aref, Saeed Samarghandian, Pooyan Makvandi, Haroon Khan, Michael R Hamblin, Milad Ashrafizadeh, Ali Zarrabi

Article2020

Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways

Reza Bagherian, Rajab Mardani, Bostan Roudi, Mohsen Taghizadeh, Hamid Reza Banfshe, Amir Ghaderi, Amirhossein Davoodvandi, Samane Shamollaghamsari, Michael R Hamblin, Hamed Mirzaei

Article2010

Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology

Simone Mocellin, Jeff Shrager, Richard A Scolyer, Sandro Pasquali, Daunia Verdi, Francesco M. Marincola, Marta Briarava, Randy Gobbel, Carlo Riccardo Rossi, Donato Nitti

Article2018

Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　― The Fushimi AF Registry ―

Nobutoyo Masunaga, Mitsuru Abe, Hisashi Ogawa, Yuya Aono, Syuhei Ikeda, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Professor Gregory Lip, Masaharu Akao

Article2022

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective

Maria A. Rocca, Menno M. Schoonheim, Paola Valsasina, Jeroen J.G. Geurts, Massimo Filippi

Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

Discussion(0)

Related publications

Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems

Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways

Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology

Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation ― The Fushimi AF Registry ―

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective

Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　― The Fushimi AF Registry ―